Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shaldon

Showing results (41-50 of 158) with videos related to

Pageof 16
Sort By:
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1981
Role of small molecule removal in the control of treatment morbidity with haemodialysis and haemofiltrationS Shaldon
The International Journal of Artificial Organs|April 1, 1996
Biocompatibility: is it a relevant consideration for today's haemodialysis?S Shaldon, J Vienken
Blood Purification|January 1, 1996
Treatment of multiorgan failureS Jørstad, S Shaldon
Kidney International. Supplement|February 1, 1975
The past, present and future of home dialysisS Shaldon, R E Crockett
Nephron|January 1, 1974
Editorial: Symposium on dialysisS Shaldon, R E Crockett
Life Support Systems : the Journal of the European Society for Artificial Organs|October 1, 1987
The relationship between biocompatibility and interleukin-1S Shaldon, C A Dinarello
Kidney International. Supplement|December 1, 1985
Are standards and checklists needed in uremia therapy?S Shaldon, K M Koch
Nephron|January 1, 1991
Survival and adequacy in long-term hemodialysisS Shaldon, K M Koch
Artificial Organs|May 1, 1995
Biocompatibility in hemodialysis: clinical relevance in 1995S Shaldon, K M Koch
Contributions to Nephrology|January 1, 1989
Cytokine relevance in biocompatibilityS Shaldon, G Lonnemann, K M Koch
Pageof 16

Showing results (41-50 of 158) with videos related to

Sort By:
Pageof 16
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1981
Role of small molecule removal in the control of treatment morbidity with haemodialysis and haemofiltrationS Shaldon
The International Journal of Artificial Organs|April 1, 1996
Biocompatibility: is it a relevant consideration for today's haemodialysis?S Shaldon, J Vienken
Blood Purification|January 1, 1996
Treatment of multiorgan failureS Jørstad, S Shaldon
Kidney International. Supplement|February 1, 1975
The past, present and future of home dialysisS Shaldon, R E Crockett
Nephron|January 1, 1974
Editorial: Symposium on dialysisS Shaldon, R E Crockett
Life Support Systems : the Journal of the European Society for Artificial Organs|October 1, 1987
The relationship between biocompatibility and interleukin-1S Shaldon, C A Dinarello
Kidney International. Supplement|December 1, 1985
Are standards and checklists needed in uremia therapy?S Shaldon, K M Koch
Nephron|January 1, 1991
Survival and adequacy in long-term hemodialysisS Shaldon, K M Koch
Artificial Organs|May 1, 1995
Biocompatibility in hemodialysis: clinical relevance in 1995S Shaldon, K M Koch
Contributions to Nephrology|January 1, 1989
Cytokine relevance in biocompatibilityS Shaldon, G Lonnemann, K M Koch
Pageof 16